Home  >  Products  >  EIF5A2 (eukaryotic translation initiation factor 5A2) Blocking Peptide (the N terminal of EIF5A2)(100ug)
EIF5A2 (eukaryotic translation initiation factor 5A2) Blocking Peptide (the N terminal of EIF5A2)(100ug)

EIF5A2 (eukaryotic translation initiation factor 5A2) Blocking Peptide (the N terminal of EIF5A2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EIF5A2 Antibody(ARP57402_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57402
Size: 100ug
Weight: 17kDa
Gene: 56648
Format: Lyophilized powder
Target: EIF5A2 is a mRNA-binding protein involved in translation elongation. EIF5A2 has an important function at the level of mRNA turnover, probably acting downstream of decapping.EIF5A2 is involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. EIF5A2 functions as a regulator of apoptosis.EIF5A2 mediates effects of polyamines on neuronal process extension and survival.EIF5A2 may play an important role in brain development and function, and in skeletal muscle stem cell differentiation.
Alternative names: EIF-5A2; eIF5AII